![Quanterix Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png?tr=w-200)
Quanterix Corp
NASDAQ:QTRX
![Quanterix Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12.23
28.66
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png)
Intrinsic Value
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. [ Read More ]
The intrinsic value of one
QTRX
stock under the Base Case scenario is
23.55
USD.
Compared to the current market price of 15.83 USD,
Quanterix Corp
is
Undervalued by 33%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png?tr=w-200)
Valuation Backtest
Quanterix Corp
Run backtest to discover the historical profit from buying and selling
QTRX
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Quanterix Corp
Current Assets | 366.8m |
Cash & Short-Term Investments | 301.9m |
Receivables | 29.3m |
Other Current Assets | 35.6m |
Non-Current Assets | 45m |
PP&E | 35.2m |
Intangibles | 5.3m |
Other Non-Current Assets | 4.4m |
Current Liabilities | 32.2m |
Accounts Payable | 3.9m |
Accrued Liabilities | 18.1m |
Other Current Liabilities | 10.2m |
Non-Current Liabilities | 38.1m |
Other Non-Current Liabilities | 38.1m |
Earnings Waterfall
Quanterix Corp
Revenue
|
126m
USD
|
Cost of Revenue
|
-52.6m
USD
|
Gross Profit
|
73.3m
USD
|
Operating Expenses
|
-127.6m
USD
|
Operating Income
|
-54.2m
USD
|
Other Expenses
|
17.9m
USD
|
Net Income
|
-36.3m
USD
|
Free Cash Flow Analysis
Quanterix Corp
USD | |
Free Cash Flow | USD |
QTRX Profitability Score
Profitability Due Diligence
Quanterix Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png)
Score
Quanterix Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
QTRX Solvency Score
Solvency Due Diligence
Quanterix Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png)
Score
Quanterix Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
QTRX Price Targets Summary
Quanterix Corp
According to Wall Street analysts, the average 1-year price target for
QTRX
is 23.46 USD
with a low forecast of 10.1 USD and a high forecast of 33.6 USD.
Ownership
QTRX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Price Appreciation
QTRX Price
Quanterix Corp
Average Annual Return | -2.77% |
Standard Deviation of Annual Returns | 68.03% |
Max Drawdown | -92% |
Market Capitalization | 605.5m USD |
Shares Outstanding | 38 000 000 |
Percentage of Shares Shorted | 5.01% |
Company Profile
![Quanterix Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png?tr=w-200)
![Quanterix Corp Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/qtrx.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.
Contact
IPO
Employees
Officers
The intrinsic value of one
QTRX
stock under the Base Case scenario is
23.55
USD.
Compared to the current market price of 15.83 USD,
Quanterix Corp
is
Undervalued by 33%.